Mycobacterium tuberculosis Acr1 Protein Mitigates Experimental Autoimmune Encephalomyelitis Symptoms by Generating Myeloid‐Derived Suppressor Cells and Regulatory T Cells
Immunology · 2026
DOI: 10.1111/imm.70050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Taruna Lamba und 12 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Laboratory, Department of Biomedical Engineering, Indian Institute of Ropar, Rupnagar, India. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Myeloid-Derived Suppressor Cells, T-Lymphocytes, Regulatory, Mycobacterium tuberculosis. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Scheme for Promotion of Academic and Research Collaboration, Indian Institute of Technology Ropar, Indian Council of Medical Research.
Abstract (Originalsprache)
Mycobacterium tuberculosis ( Mtb ) effectively suppresses host immunity to ensure its survival. We have earlier shown that the Acr1 protein of Mtb can inhibit the differentiation of dendritic cells (DCs). Consequently, in the current study, we examined the role of Acr1 in mitigating autoimmunity. Initially, we observed that Acr1 skews the differentiation of DCs into functionally competent myeloid‐derived suppressor cells (MDSC Acr1 ) that chiefly secrete immunosuppressive molecules, expand regulatory T cells (Treg Acr1 ) and attenuate inflammatory responses. Further, MDSC Acr1 suppress Th17 cells. Acr1 expanded MDSCs with a concurrent increase in myelin oligodendrocyte glycoprotein (MOG)‐specific Tregs and a decline in Th17 cells in a murine experimental autoimmune encephalomyelitis (EAE) model and prevented the onset of the disease. These results were further validated in the prophylactic model of EAE. Mechanistically, Acr1 activates Tregs and MDSCs via the TLR‐4 pathway, implicating innate immune recognition in Mtb ‐induced suppression. The results indicate a potential role of Acr1 against autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Laboratory, Department of Biomedical Engineering, Indian Institute of Ropar, Rupnagar, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research, Mohali, India.
- Institute of Microbial Technology, Chandigarh, India.
- CSIR-Central Drug Research Institute, Lucknow, India.
ORCID-Profile: Sharvan Sehrawat, Javed N Agrewala
Förderung
- Scheme for Promotion of Academic and Research Collaboration
- Indian Institute of Technology Ropar
- Indian Council of Medical Research
- CSIR-UGC
- MHRD
- PMRF is Prime Minister's Research Fellowship
- DST-Inspire
- Ministry of Education, India
Zitieren
APA
Lamba, T., Zafar, M. A., Shaaz, M., Singh, S., Singh, S., Khan, M. A., Prajapati, S., Malik, J. A., Nanda, S., Siddiqui, K. F., Arora, A., Sehrawat, S., & Agrewala, J. N. (2026). Mycobacterium tuberculosis Acr1 Protein Mitigates Experimental Autoimmune Encephalomyelitis Symptoms by Generating Myeloid‐Derived Suppressor Cells and Regulatory T Cells. Immunology. https://doi.org/10.1111/imm.70050
Vancouver
Lamba T, Zafar MA, Shaaz M, Singh S, Singh S, Khan MA, et al. Mycobacterium tuberculosis Acr1 Protein Mitigates Experimental Autoimmune Encephalomyelitis Symptoms by Generating Myeloid‐Derived Suppressor Cells and Regulatory T Cells. Immunology. 2026. doi:10.1111/imm.70050
BibTeX
@article{Lamba2026,
author = {Lamba, Taruna and Zafar, Mohammad Adeel and Shaaz, Mohammad and Singh, Sanpreet and Singh, Sudhakar and Khan, Mohd Affan and Prajapati, Shivank and Malik, Junaid A and Nanda, Sidhanta and Siddiqui, Kaneez F and Arora, Ashish and Sehrawat, Sharvan and Agrewala, Javed N},
title = {Mycobacterium tuberculosis Acr1 Protein Mitigates Experimental Autoimmune Encephalomyelitis Symptoms by Generating Myeloid‐Derived Suppressor Cells and Regulatory T Cells},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70050}
}
EUVIMED